Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · August 25, 2022

Efficacy of Diltiazem to Improve Coronary Vasomotor Dysfunction in Patients With ANOCA

JACC: Cardiovascular Imaging


Additional Info

JACC: Cardiovascular Imaging
Efficacy of Diltiazem to Improve Coronary Vasomotor Dysfunction in ANOCA: The EDIT-CMD Randomized Clinical Trial
JACC Cardiovasc Imaging 2022 Aug 01;15(8)1473-1484, TPJ Jansen, RE Konst, A de Vos, V Paradies, S Teerenstra, SCH van den Oord, A Dimitriu-Leen, AHEM Maas, PC Smits, P Damman, N van Royen, SE Elias-Smale

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading